RE
ARKG icon

Rydar Equities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Rydar Equities’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.6K Buy
+390
New +$17.5K 0.01% 257

Other funds holding ARKG

MFPI
Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return
GF
Gimbal Financial Carmel, Indiana $172M AUM
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
CFIM
Client First Investment Management West Bend, Wisconsin $210M AUM 50.85% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $146M AUM 18.19% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
PWM
Purus Wealth Management Newport Beach, California $366M AUM 31.29% 1-Year Est. Return
PFG Advisors
PFG Advisors Phoenix, Arizona $1.96B AUM 19.12% 1-Year Est. Return
CA
Cambridge Advisors Omaha, Nebraska $581M AUM 12.85% 1-Year Est. Return

Rydar Equities's ARKG Position: Q3 2026 in Review

Rydar Equities opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 390 shares worth $19.6K. The stake represents 0.01% of the portfolio and ranks #257 among its holdings.

48 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • Rydar Equities held 390 shares of ARK Genomic Revolution ETF worth $19.6K as of Q3 2026.
  • ARK Genomic Revolution ETF was a new Rydar Equities position in Q3 2026.
  • ARK Genomic Revolution ETF made up 0.01% of Rydar Equities's portfolio in Q3 2026, its #257 holding.
  • 48 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Rydar Equities's 13F filing for Q3 2026, filed 13 Oct 2026.